Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Vanhoorelbeke

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Blood|November 26, 2016
Glycans of plasma ADAMTS13Karen Vanhoorelbeke
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Determining ADAMTS13 Conformation for the Diagnosis of Immune Thrombotic Thrombocytopenic Purpura and Prediction of RelapseQuintijn Bonnez, Karen Vanhoorelbeke
Hemasphere|July 28, 2025
Open or closed? Understanding the molecular mechanisms and clinical implications of ADAMTS13's conformationQuintijn Bonnez, Karen Vanhoorelbeke
Journal of Clinical Medicine|October 14, 2023
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic PurpuraQuintijn Bonnez, Kazuya Sakai, Karen Vanhoorelbeke
Current Opinion in Hematology|August 3, 2020
Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and managementElien Roose, Agnès Veyradier, Karen Vanhoorelbeke
Acta Haematologica|June 10, 2009
ADAMTS13 in health and diseaseHendrik B Feys, Hans Deckmyn, Karen Vanhoorelbeke
Intensive Care Medicine|January 25, 2017
Understanding therapeutic targets in thrombotic thrombocytopenic purpuraBérangère S Joly, Karen Vanhoorelbeke, Agnès Veyradier
Current Opinion in Hematology|May 9, 2024
Improving our understanding on the clinical role of plasmin-mediated von Willebrand factor degradationHinde El Otmani, Karen Vanhoorelbeke, Claudia Tersteeg
Frontiers in Immunology|January 11, 2020
von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in StrokeFrederik Denorme, Karen Vanhoorelbeke, Simon F De Meyer
Journal of Thrombosis and Haemostasis : JTH|May 22, 2026
Wrapping it Up: Structural Basis of ADAMTS13 Global LatencyNorman Geist, Quintijn Bonnez, Karen Vanhoorelbeke, et al.
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Blood|November 26, 2016
Glycans of plasma ADAMTS13Karen Vanhoorelbeke
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Determining ADAMTS13 Conformation for the Diagnosis of Immune Thrombotic Thrombocytopenic Purpura and Prediction of RelapseQuintijn Bonnez, Karen Vanhoorelbeke
Hemasphere|July 28, 2025
Open or closed? Understanding the molecular mechanisms and clinical implications of ADAMTS13's conformationQuintijn Bonnez, Karen Vanhoorelbeke
Journal of Clinical Medicine|October 14, 2023
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic PurpuraQuintijn Bonnez, Kazuya Sakai, Karen Vanhoorelbeke
Current Opinion in Hematology|August 3, 2020
Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and managementElien Roose, Agnès Veyradier, Karen Vanhoorelbeke
Acta Haematologica|June 10, 2009
ADAMTS13 in health and diseaseHendrik B Feys, Hans Deckmyn, Karen Vanhoorelbeke
Intensive Care Medicine|January 25, 2017
Understanding therapeutic targets in thrombotic thrombocytopenic purpuraBérangère S Joly, Karen Vanhoorelbeke, Agnès Veyradier
Current Opinion in Hematology|May 9, 2024
Improving our understanding on the clinical role of plasmin-mediated von Willebrand factor degradationHinde El Otmani, Karen Vanhoorelbeke, Claudia Tersteeg
Frontiers in Immunology|January 11, 2020
von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in StrokeFrederik Denorme, Karen Vanhoorelbeke, Simon F De Meyer
Journal of Thrombosis and Haemostasis : JTH|May 22, 2026
Wrapping it Up: Structural Basis of ADAMTS13 Global LatencyNorman Geist, Quintijn Bonnez, Karen Vanhoorelbeke, et al.
Pageof 20